These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9004388)

  • 1. An approach to estimating exposure-specific rates of breast cancer from a two-stage case-control study within a cohort.
    Benichou J; Byrne C; Gail M
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):133-51. PubMed ID: 9004388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
    Taylor R; Boyages J
    J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project.
    Brisson J; Morrison AS; Khalid N
    J Natl Cancer Inst; 1988 Dec; 80(19):1534-40. PubMed ID: 3255294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project.
    Byrne C; Smart CR; Chu KC; Hartmann WH
    Cancer; 1994 Jul; 74(1 Suppl):301-10. PubMed ID: 8004601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projections of the breast cancer burden to U.S. women: 1990-2000.
    Kessler LG; Feuer EJ; Brown ML
    Prev Med; 1991 Jan; 20(1):170-82. PubMed ID: 2008426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the sensitivity of breast cancer screening--experience with the Honolulu BCDDP data.
    Grove JS; Goodman MJ; Gilbert FI; Low G
    Breast Cancer Res Treat; 1991 May; 18 Suppl 1():S97-101. PubMed ID: 1873566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are breast density and bone mineral density independent risk factors for breast cancer?
    Kerlikowske K; Shepherd J; Creasman J; Tice JA; Ziv E; Cummings SR
    J Natl Cancer Inst; 2005 Mar; 97(5):368-74. PubMed ID: 15741573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
    Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
    BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Ernster V
    JAMA; 1996 Jul; 276(1):39-43. PubMed ID: 8667537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer.
    Moss SM; Summerley ME; Thomas BT; Ellman R; Chamberlain JO
    J Epidemiol Community Health; 1992 Aug; 46(4):362-4. PubMed ID: 1431707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian National Breast Screening Study: first screen results as predictors of future breast cancer risk.
    Holowaty PH; Miller AB; Baines CJ; Risch H
    Cancer Epidemiol Biomarkers Prev; 1993; 2(1):11-9. PubMed ID: 8420606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
    Passaperuma K; Warner E; Hill KA; Gunasekara A; Yaffe MJ
    J Clin Oncol; 2010 Aug; 28(23):3779-83. PubMed ID: 20625126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
    Berrington de Gonzalez A; Berg CD; Visvanathan K; Robson M
    J Natl Cancer Inst; 2009 Feb; 101(3):205-9. PubMed ID: 19176458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.